Get The Alerts + Report

BeOne Medicines Ltd. [ONC]

Reporting date: 10/08/2025

⚠️ Neutral Insider Mix Detected

📝 What Happened

  • Insider: Lee Chan Henry
  • Role: SVP, General Counsel (Officer)
  • Company: BeOne Medicines Ltd. (ONC)
  • Transaction Date(s): 2025-10-08
  • Table I (Non-Derivative Securities)
    • Sale : 10,671
    • Average Sale Price: $350.40
    • Total Value: $3,739,118.40
    • Post-Transaction Direct Holdings: 223,106 Ordinary Shares (direct)
    • Indirect Holdings: 0
    • 10b5-1 Plan Used? Yes

📄 Summary

Lee Chan Henry, SVP, General Counsel at BeOne Medicines Ltd. (ONC), mixed 20,230 American Depositary Shares on October 08, 2025, at an average sale price of $350.40, realizing proceeds of about ~$3,739,118. After the transactions, he now holds 223,106 Ordinary Shares (direct) and retains derivative interests (options) covering underlying ordinary shares (specified in filings). For retail traders, this is a neutral-to-slightly bearish event: largely planned selling with offsetting acquisitions and option activity.

🔑 Interpretation

  • Type: Combination — largely comp-related (vestings/options and awards) and a Rule 10b5-1 planned sale (discretionary execution via plan).
  • Disposition: Sales were executed (shares sold); acquisitions increased direct/option holdings rather than being immediately sold.
  • Size Context: Gross traded volume (20,230 ADS) is moderate relative to overall direct and option holdings reported; net effect is a small net sale (≈1,112 ADS) consistent with routine profit-taking under a 10b5-1 plan.
  • ATH Metric: Trades executed around ~$350 per ADS. That price level is near recent trading highs for this security (i.e., the sales occurred at elevated, near-term price levels), so timing appears opportunistic versus multi-month lows rather than a fire-sale at depressed prices.
  • Outlier Check: Not unusually large compared with the combination of option vesting/acquisitions and a planned selling program disclosed in the filing; activity appears consistent with scheduled vesting and an established 10b5-1 plan.

📊 Bullish or Bearish?

Decide: Neutral

Neutral. The filing shows both material sales (10,671 ADS) executed under a 10b5-1 plan and contemporaneous acquisitions/vesting (9,559 ADS acquired/awarded), yielding a small net sale — indicative of planned profit-taking and compensation-related activity rather than a clear negative signal. Data completeness is good for this filing but cluster activity cannot be determined from this filing alone.

✅ Bottom Line (Retail Takeaway)

This transaction looks like routine profit-taking and option/vesting activity executed in part under a 10b5-1 plan rather than a clear bearish signal. For retail traders, it’s largely noise — not a strong short-/mid-term trading signal absent corroborating insider sales from multiple senior executives or a broader selling pattern.